Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Return on Capital Employed (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Return on Capital Employed for 14 consecutive years, with 0.45% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 19.0% to 0.45% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.45% through Dec 2025, down 19.0% year-over-year, with the annual reading at 0.41% for FY2025, 4.0% up from the prior year.
  • Return on Capital Employed hit 0.45% in Q4 2025 for Perspective Therapeutics, down from 0.42% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.01% in Q2 2021 to a low of 0.46% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 0.21% across 5 years, with a median of 0.18% in 2024.
  • Biggest five-year swings in Return on Capital Employed: soared 46bps in 2021 and later tumbled -31bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.05% in 2021, then tumbled by -204bps to 0.15% in 2022, then crashed by -202bps to 0.46% in 2023, then surged by 44bps to 0.26% in 2024, then plummeted by -72bps to 0.45% in 2025.
  • Business Quant data shows Return on Capital Employed for CATX at 0.45% in Q4 2025, 0.42% in Q3 2025, and 0.36% in Q2 2025.